In this study, public databases, bioinformatics analyses, and validation with clinical tissue samples were employed to demonstrate that CD302 is downregulated in LUAD tissues, with its expression negatively correlated with tumor diameter and exhibiting high diagnostic efficacy. This evidence concerns the gene CD302 and neoplasm.